4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-23-000062
Director sold 41,980 shares at an average $8.71 ($365,780)
- Director acquired 6,459 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Freitag Gregory Gene · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-01 | Sale : show line 1 in the form | −12,500 | $8.65 | $108,125 | 319,615 | D |
| 2023-06-01 | Sale : show line 2 in the form | −29,480 | $8.74 | $257,655 | 290,135 | D |
| 2023-06-01 | Exercise or conversion : show line 3 in the form | +6,459 | 296,594 | D | ||
| Open-market sales · 41,980 sh · avg $8.71 · $365,780 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-01 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −6,459 | 0 | D |
Loading xslF345X04/wf-form4_168600524446062.xml…